Retrospective study of intravitreal aflibercept injections in treatment-naive patients with exudative age-related macular degeneration to assess the correlation between outer retinal layer and external limiting membrane changes with fluid response and visual improvement.

Trial Profile

Retrospective study of intravitreal aflibercept injections in treatment-naive patients with exudative age-related macular degeneration to assess the correlation between outer retinal layer and external limiting membrane changes with fluid response and visual improvement.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2015

At a glance

  • Drugs Aflibercept (Primary)
  • Indications Age-related macular degeneration
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top